KBH-A402

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKBH-A402
Drug Alias NameTACE inhibitor (KRIBB/Jeil)anti-inflammatory (Korea Research Instiute of Bioscience and Biotechnology)KBH-A402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 17 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 17
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorean Research Institute of Bioscience and Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorean Research Institute of Bioscience and BiotechnologyJeil Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A